Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands

被引:53
作者
Caragounis, Aphrodite
Du, Tai
Filiz, Gulay
Laughton, Katrina M.
Volitakis, Irene
Sharples, Robyn A.
Cherny, Robert A.
Masters, Colin L.
Drew, Simon C.
Hill, Andrew F.
Li, Qiao-Xin
Crouch, Peter J.
Barnham, Kevin J.
White, Anthony R. [1 ]
机构
[1] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[2] Mental Hlth Res Inst, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia
[4] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3052, Australia
[5] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia
关键词
Alzheimer's disease; amyloid; c-Jun N-terminal kinase (INK); copper; metal complex; metal loprotease;
D O I
10.1042/BJ20070579
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biometals have an important role in AD (Alzheimer's disease) and metal ligands have been investigated as potential therapeutic agents for treatment of AD. In recent studies the 8HQ (8-hydroxy-quinoline) derivative CQ (clioquinol) has shown promising results in animal models and small clinical trials; however, the actual mode of action in vivo is still being investigated. We previously reported that CQ-metal complexes up-regulated MMP (matrix metalloprotease) activity in vitro by activating PI3K (phosphoinositide 3-kinase) and JNK (c-jun N-terminal kinase), and that the increased MMP activity resulted in enhanced degradation of secreted A ss (amyloid ss) peptide. In the present study, we have further investigated the biochemical mechanisms by which metal ligands affect A ss metabolism. To achieve this, we measured the effects of diverse metal ligands on cellular metal uptake and secreted A ss levels in cell culture. We report that different classes of metal ligands including 8HQ and phenanthroline derivatives and the sulfur compound PDTC (pyrrolidine dithiocarbamate) elevated cellular metal levels (copper and zinc), and resulted in substantial loss of secreted A ss. Generally, the ability to inhibit A ss levels correlated with a higher lipid solubility of the ligands and their capacity to increase metal uptake. However, we also identified several ligands that potently inhibited A ss levels while only inducing minimal change to cellular metal levels. Metal ligands that inhibited A ss levels [e.g. CQ, 8HQ, NC (neocuproine), 1,10-phenanthroline and PDTC] induced metal-dependent activation of PI3K and JNK, resulting in JNK-mediated up-regulation of metalloprotease activity and subsequent loss of secreted A ss. The findings in the present study show that diverse metal ligands with high lipid solubility can elevate cellular metal levels resulting in metalloprotease-dependent inhibition of A ss. Given that a structurally diverse array of ligands was assessed, the results are consistent with the effects being due to metal transport rather than the chelating ligand interacting directly with a receptor.
引用
收藏
页码:435 / 450
页数:16
相关论文
共 47 条
  • [1] Differential production of metalloproteinases after instilling various urban air particle samples to rat lung
    Adamson, IYR
    Vincent, R
    Bakowska, J
    [J]. EXPERIMENTAL LUNG RESEARCH, 2003, 29 (06) : 375 - 388
  • [2] Cleavage of amyloid-β precursor protein (APP) by membrane-type matrix metalloproteinases
    Ahmad, M
    Takino, T
    Miyamori, H
    Yoshizaki, T
    Furukawa, M
    Sato, H
    [J]. JOURNAL OF BIOCHEMISTRY, 2006, 139 (03) : 517 - 526
  • [3] Characterization of copper interactions with Alzheimer amyloid β peptides:: Identification of an attomolar-affinity copper binding site on amyloid β1-42
    Atwood, CS
    Scarpa, RC
    Huang, XD
    Moir, RD
    Jones, WD
    Fairlie, DP
    Tanzi, RE
    Bush, AI
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) : 1219 - 1233
  • [4] Structure of the Alzheimer's disease amyloid precursor protein copper binding domain - A regulator of neuronal copper homeostasis
    Barnham, KJ
    McKinstry, WJ
    Multhaup, G
    Galatis, D
    Morton, CJ
    Curtain, CC
    Williamson, NA
    White, AR
    Hinds, MG
    Norton, RS
    Beyreuther, K
    Masters, CL
    Parker, MW
    Cappai, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) : 17401 - 17407
  • [5] Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions:: Mechanisms and consequences
    Barthel, Andreas
    Ostrakhovitch, Elena A.
    Walter, Philippe L.
    Kampkoetter, Andreas
    Klotz, Lars-Oliver
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 463 (02) : 175 - 182
  • [6] Copper inhibits β-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion
    Borchardt, T
    Camakaris, J
    Cappai, R
    Masters, CL
    Beyreuther, K
    Multhaup, G
    [J]. BIOCHEMICAL JOURNAL, 1999, 344 : 461 - 467
  • [7] RAPID INDUCTION OF ALZHEIMER A-BETA AMYLOID FORMATION BY ZINC
    BUSH, AI
    PETTINGELL, WH
    MULTHAUP, G
    PARADIS, MD
    VONSATTEL, JP
    GUSELLA, JF
    BEYREUTHER, K
    MASTERS, CL
    TANZI, RE
    [J]. SCIENCE, 1994, 265 (5177) : 1464 - 1467
  • [8] BUSH AI, 1993, J BIOL CHEM, V268, P16109
  • [9] Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts
    Chen, Di
    Cui, Qiuzhi Cindy
    Yang, Huanjie
    Barrea, Raul A.
    Sarkar, Fazlul H.
    Sheng, Shijie
    Yan, Bing
    Reddy, G. Prem Veer
    Dou, Q. Ping
    [J]. CANCER RESEARCH, 2007, 67 (04) : 1636 - 1644
  • [10] Chen SH, 2000, GLIA, V31, P249, DOI 10.1002/1098-1136(200009)31:3<249::AID-GLIA60>3.0.CO